Arterial stiffness and stroke in hypertension: Therapeutic implications for stroke prevention

CNS Drugs

Volumn 19, Issue 1, 2005, Pages 1-11

  Laurent, Stéphane ^a   Boutouyrie, Pierre ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CELIPROLOL; DILEVALOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOSARTAN; PERINDOPRIL; PINDOLOL; PROPRANOLOL; RENIN; SIMVASTATIN; VASODILATOR AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTERY STIFFNESS; CARDIOVASCULAR RISK; CAROTID ARTERY; CAUSE OF DEATH; CHINA; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DYSLIPIDEMIA; FEMORAL ARTERY; FOLLOW UP; HIGH RISK POPULATION; HUMAN; HYPERTENSION; JAPAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MEAN ARTERIAL PRESSURE; METHODOLOGY; MORTALITY; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; PULSE WAVE; REVIEW; RISK FACTOR; SMOKING; STROKE; VASCULAR PATENCY; VELOCITY;

ANIMALS; ARTERIES; CEREBROVASCULAR ACCIDENT; HUMANS; HYPERTENSION; PREDICTIVE VALUE OF TESTS; RISK FACTORS; VASCULAR RESISTANCE;

EID: 12844256369     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-200519010-00001     Document Type: Review

References (88)

1. Bonita R. Stroke prevention: a global perspective. In: Norris JW, Hachinski V, editors. Stroke Prevention. New York, NY: Oxford University Press; 2001: 259-74
2. Gorelick PB. Stroke prevention therapy beyond antithrombotics: unifying mechanisms in ischemic stroke pathogenesis and implications for therapy. An invited review. Stroke 2002; 33: 862-75
3. Nichols WW, O'Rourke MF, Hartley C, et al., editors. McDonald's blood flow in arteries: theoretical, experimental and clinical principles. 3rd ed. London: Arnold Publication, 1990: 77-142, 216-69, 283-359, 398-37
4. Weber T, Auer J, O'Rourke MF, et al. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation 2004; 109: 184-9
5. Wilkinson IB, Franklin SS, Hall IR, et al. Pressure amplification explains why pulse pressure is unrelated to risk in young subjects. Hypertension 2001; 38: 1461-6
6. Leung DY, Glagov S, Mathews MB. Cyclic stretching stimulates synthesis of matrix components by arterial smooth muscle cells in vitro. Science 1976; 191: 475-7
7. Reusch P, Wagdy H, Reusch R, et al. Mechanical strain increases smooth muscle and decreases nonmuscle myosin expression in rat vascular smooth muscle cells. Circ Res 1996; 79: 1046-53
8. Niklason LE, Gao J, Abbott WM, et al. Functional arteries grown in vitro. Science 1999; 284: 489-93
9. Salonen R, Salonen JT. Determinants of carotid intima-media thickness: a population-based ultrasonography study in eastern Finnish men. J Intern Med 1991; 229: 225-31
10. Witteman JC, Grobbee DE, Valkenburg HA, et al. J-shaped relation between change in diastolic blood pressure and progression of aortic atherosclerosis. Lancet 1994; 343: 504-7
11. Boutouyrie P, Bussy C, Lacolley P, et al. Association between local pulse pressure and large artery remodeling. Circulation 1999; 100: 1087-93
12. Cheng GC, Loree HM, Kamm RD, et al. Distribution of circumferential stress in ruptured and stable atherosclerotic lesions: a structural analysis with histopathological correlation. Circulation 1993; 87: 1179-87
13. Liao D, Cooper L, Cai J, et al. The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: the ARIC Study. Neuroepidemiology 1997; 16: 149-62
14. De Leeuw FE, de Groot JC, Bots ML, et al. Carotid atherosclerosis and cerebral white matter lesions in a population based magnetic resonance imaging study. J Neurol 2000; 247: 291-6
15. Masawa N, Yoshida Y, Yamada T, et al. Morphometry of structural preservation of tunica media in aged and hypertensive human intracerebral arteries. Stroke 1994; 25: 122-7
16. Heistad DD, Armstrong ML, Baumbach GL, et al. Sick vessel syndrome: recovery of atherosclerotic and hypertensive vessels. Hypertension 1995; 26: 509-13
17. Boutouyrie P, Tropeano AI, Asmar R, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 2002; 39: 10-5
18. Chae CU, Pfeffer MA, Glynn RJ, et al. Increased pulse pressure and risk of heart failure in the elderly. JAMA 1999; 281: 634-9
19. Safar ME. Pulse pressure in essential hypertension: clinical and therapeutical implications. J Hypertens 1989; 7: 769-76
20. Boutouyrie P, Laurent S, Girerd X, et al. Common carotid artery distensibility and patterns of left ventricular hypertrophy in hypertensive patients. Hypertension 1995; 25 (1): 651-9
21. Benetos A, Safar M, Rudnichi A, et al. Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension 1997; 30: 1410-5
22. Franklin SS, Khan SA, Wong ND, et al. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation 1999; 100: 354-60
23. Mitchell GF, Moye LA, Braunwald E, et al. Sphygmomanometric determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function. Circulation 1997; 96: 4254-60
24. Chae CU, Pfeffer MA, Glynn RJ, et al. Increased pulse pressure and risk of heart failure in the elderly. JAMA 1999; 281: 634-9
25. Lawes CM, Bennett DA, Feigin VL, et al. Blood pressure and stroke: an overview of published reviews. Stroke 2004; 35: 776-85
26. Benetos A, Rudnichi A, Safar ME, et al. Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects. Hypertension 1998; 32: 560-4
27. Verdecchia P, Scillaci G, Borgioni C, et al. Ambulatory pulse pressure: a potent predictor of total cardiovascular risk in hypertension. Hypertension 1998; 32: 983-8
28. Zhang XF, Attia J, D'Este C, et al. Prevalence and magnitude of classical risk factors for stroke in a cohort of 5092 Chinese steelworkers over 13.5 years of follow-up. Stroke 2004; 35: 1052-6
29. Kannel WB, Wolf PA, McGee DL, et al. Systolic blood pressure, arterial rigidity, and risk of stroke. JAMA 1981; 245: 1225-9
30. Nielsen WB, Lindenstrom E, Vestbo J, et al. Is diastolic hypertension an independent risk factor for stroke in the presence of normal systolic blood pressure in the middle-aged and elderly? Am J Hypertens 1997; 10: 634-9
31. Domanski MJ, Davis BR, Pfeffer MA, et al. Isolated systolic hypertension: prognostic information provided by pulse pressure. Hypertension 1999; 34: 375-80
32. Millar JA, Lever AF. Implications of pulse pressure as a predictor of cardiac risk in patients with hypertension. Hypertension 2000; 36: 907-11
33. Gueyffier F, Boissel JP, Pocock S, et al. Identification of risk factors in hypertensive patients: contribution of randomized controlled trials through an individual patient database. Circulation 1999; 100: e88-94
34. Gasowski J, Fagard RH, Staessen JA, et al. Pulsatile blood pressure component as predictor of mortality in hypertension: a meta-analysis of clinical trial control groups. J Hypertens 2002; 20: 145-51
35. Staessen JA, Thijs L, O'Brien ET, et al. Ambulatory pulse pressure as predictor of outcome in older patients with systolic hypertension. Am J Hypertens 2002; 15 (10 Pt 1): 835-43
36. London GM, Guerin AP, Pannier BM, et al. Body height as a determinant of carotid pulse contour in humans. J Hypertens Suppl 1992; 10: S93-95
37. Baumbach GL, Siems JE, Heistad DD. Effects of local reduction in pressure on distensibility and composition of cerebral arterioles. Circ Res 1991; 68: 338-51
38. Liao D, Cooper L, Cai J, et al. The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: the ARIC Study. Neuroepidemiology 1997; 16: 149-62
39. Bramwell JC, Hill AV. The velocity of the pulse wave in man. Proc R Soc 1922; 93: 298-306
40. Pannier BM, Avolio AP, Hoeks A, et al. Methods and devices for measuring arterial compliance in humans. Am J Hypertens 2002; 15: 743-53
41. Asmar R, Benetos A, Topouchian J, et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement: validation and clinical application studies. Hypertension 1995; 26: 485-90
42. Blacher J, Asmar R, Djane S, et al. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999; 33: 1111-7
43. Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236-41
44. Blacher J, Guerin AP, Pannier B, et al. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 99: 2434-9
45. Blacher J, Pannier B, Guerin A, et al. Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension 1998; 32: 570-4
46. de Simone G, Roman MJ, Koren MJ, et al. Stroke volume/pulse pressure ratio and cardiovascular risk in arterial hypertension. Hypertension 1999; 33: 800-5
47. Laurent S, Katsahian S, Fassot C, et al. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke 2003; 34: 1203-6
48. Guerin AP, Blacher J, Pannier B, et al. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001 Feb 20; 103: 987-92
49. Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-53
50. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 Report. JAMA 2003; 289: 2560-72
51. Staessen JA, Wang J-G, Thijs L. Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet 2001; 358: 1305-15
52. Neal B, MacMahon S, Chapman N. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration. Lancet 2000; 356: 1955-64
53. Simon AC, Levenson J, Bouthier JD, et al. Effects of chrome administration of enalapril and propranolol on the large arteries in essential hypertension. J Cardiovasc Pharmacol 1985; 7: 856-91
54. Asmar RG, Pannier B, Santoni JP, et al. Reversion of cardiac hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension. Circulation 1988; 78: 941-50
55. Finkelstein SM, Collins VR, Cohn JN. Arterial vascular compliance response to vasodilators by Fourrier and pulse contour analysis. Hypertension 1988; 12: 380-7
56. Kool MJ, Lustermans FA, Breed JG, et al. The influence of perindopril and the diuretic combination amiloride + hydrochlorothiazide on the vessel wall properties of large arteries in hypertensive patients. J Hypertens 1995; 13: 839-48
57. Ting CT, Chen CH, Chang MS, et al. Short- and long-term effects of antihypertensive drugs on arterial reflections, compliance and impedance. Hypertension 1995; 26: 524-30
58. Girerd X, Giannattasio C, Moulin C, et al. Regression of radial artery wall hypertrophy and improvement of carotid artery compliance after long term antihypertensive treatment: the Pericles study. J Am Coll Cardiol 1998; 31: 1064-73
59. Boutouyrie P, Bussy C, Hayoz D, et al. Local pulse pressure and regression of arterial wall hypertrophy during long term antihypertensive treatment. Circulation 2000; 101: 2601-6
60. Laurent S, Kingwell B, Bank A, et al. Clinical applications of arterial stiffness: therapeutic and pharmacology. Am J Hypertens 2002; 15: 453-8
61. Kelly R, Daley J, Avolio A, et al. Arterial dilation and reduced wave reflection: benefit of dilevalol in hypertension. Hypertension 1989; 14: 14-21
62. Asmar RG, London GM, O'Rourke ME, et al. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol. Hypertension 2001; 38: 922-6
63. Winer N, Weber MA, Sowers JR. The effect of antihypertensive drugs on vascular compliance. Curr Hypertens Rep 2001; 3: 297-304
64. Morgan T, Lauri J, Bertram D, et al. Effect of different antihypertensive drug classes on central aortic pressure. Am J Hypertens 2004; 17: 118-23
65. Dahlof B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359: 995-1003
66. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting- enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; 342: 145-53
67. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358: 1033-41
68. Delerme S, Boutouyrie P, Laloux B, et al. Aortic stiffness is reduced beyond blood pressure lowering by short- and long-term antihypertensive treatment: a meta-analysis of individual data in 294 patients [abstract]. Hypertension 1998; 32: 789
69. Bézie Y, Daniel Lamazière JM, Laurent S, et al. Fibronectin expression and aortic wall elastic modulus in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 1998; 18: 1027-34
70. Boumaza S, Arribas S, Osborne-Pellegrin M, et al. Fenestrations of the carotid internal elastic lamina and structural adaptation in stroke-prone spontaneously hypertensive rats. Hypertension 2001; 37: 1101-7
71. Cohuet G, Challande P, Osborne-Pellegrin M, et al. Mechanical strength of the isolated carotid artery in SHR. Hypertension 2001; 38: 1167-71
72. Bank AJ, Kaiser DR, Rajala S, et al. In vivo human brachial artery elastic mechanics: effects of smooth muscle relaxation. Circulation 1999; 100: 41-7
73. Safar ME, Van Bortel LMAB, Struijker Boudier HAJ. Resistance and conduit arteries following converting enzyme inhibition in hypertension. J Vasc Res 1997; 34: 67-81
74. Benetos A, Lacolley P, Safar M. Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 1997; 17: 1152-6
75. Blacher J, Amah G, Girerd X, et al. Association between increased plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertension. Am J Hypertens 1997; 10: 1326-34
76. Lacolley P, Labat C, Pujol A, et al. Increased carotid wall elastic modulus and fibronectin in aldosterone-salt-treated rats: effects of eplerenone. Circulation 2002; 106: 2848-53
77. Van Bortel LM, Spek JJ, Balkestein EJ, et al. Is it possible to develop drugs that act more selectively on large arteries? J Hypertens 1999; 17: 701-5
78. Mitchell G, Izzo J, Lacourcière Y, et al. Omapatrilat reduces pulse pressure and proximal aortic stiffness in patients with systolic hypertension. Circulation 2002; 105: 2955-61
79. Gorelick PB, Scneck M, Berglund LF, et al. Status of lipids as a risk factor for stroke. Neuroepidemiology 1997; 16: 107-15
80. Demchuk AM, Hess DC, Brass LM, et al. Is cholesterol a risk factor for stroke? Yes. Arch Neurol 1999; 56: 1518-20
81. Sandercock P. Statins for stroke prevention. Lancet 2001; 357: 1548-9
82. Ross SD, Allen IE, Connelly JE, et al. Clinical outcomes in statin treatment trials: a meta-analysis. Arch Intern Med 1999; 159: 1793-803
83. Giannattasio C, Mangoni AA, Faila M, et al. Impaired radial artery compliance in normotensive subjects with familial hypercholesterolemia. Atherosclerosis 1996; 124: 249-60
84. Vaughan CJ, Delanty N. Neuroprotective properties of statins in cerebral ischemia and stroke. Stroke 1999; 30: 1969-73
85. Huijberts MSP, Wolffenbuttel BHR, Struijker Boudier HAJ, et al. Aminoguanidine treatment increases elasticity and decreases fluid filtration of large arteries from diabetic rats. J Clin Invest 1993; 92: 1407-13
86. Corman B, Duriez M, Poitevin P, et al. Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy. Proc Natl Acad Sci U S A 1998; 95: 1301-6
87. Wolffenbuttel BH, Boulanger CM, Crijns FR, et al. Breakers of advanced glycation end-products restore large artery properties in experimental diabetes. Proc Natl Acad Sci U S A 1998; 95: 4630-4
88. Kass DA, Shapiro EP, Kawaguchi M, et al. Improved arterial compliance by a novel advanced glycation end-product cross-link breaker. Circulation 2001; 104: 1464-70